CN112999340A - 一种鼻腔冲洗液及其制备方法 - Google Patents
一种鼻腔冲洗液及其制备方法 Download PDFInfo
- Publication number
- CN112999340A CN112999340A CN202110239600.3A CN202110239600A CN112999340A CN 112999340 A CN112999340 A CN 112999340A CN 202110239600 A CN202110239600 A CN 202110239600A CN 112999340 A CN112999340 A CN 112999340A
- Authority
- CN
- China
- Prior art keywords
- hyaluronic acid
- nasal
- nasal cavity
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003928 nasal cavity Anatomy 0.000 title claims abstract description 36
- 239000012530 fluid Substances 0.000 title claims abstract description 21
- 238000011010 flushing procedure Methods 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title abstract description 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 40
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 40
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 40
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 31
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000003814 drug Substances 0.000 claims abstract description 26
- 238000003756 stirring Methods 0.000 claims abstract description 26
- 239000011780 sodium chloride Substances 0.000 claims abstract description 23
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 23
- 102000016943 Muramidase Human genes 0.000 claims abstract description 22
- 108010014251 Muramidase Proteins 0.000 claims abstract description 22
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 22
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 22
- 239000004325 lysozyme Substances 0.000 claims abstract description 22
- 229960000274 lysozyme Drugs 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 18
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 18
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 18
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000004471 Glycine Substances 0.000 claims abstract description 13
- 241000079219 Artemisia alba Species 0.000 claims abstract description 12
- 239000008213 purified water Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 230000001954 sterilising effect Effects 0.000 claims abstract description 7
- 238000005303 weighing Methods 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 17
- 239000009670 cang er zi wan Substances 0.000 claims description 14
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 12
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 229940113601 irrigation solution Drugs 0.000 claims description 10
- 230000002829 reductive effect Effects 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 239000012535 impurity Substances 0.000 claims description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- 238000004821 distillation Methods 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- -1 small molecule sodium hyaluronate Chemical class 0.000 claims description 6
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 6
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract description 11
- 240000004534 Scutellaria baicalensis Species 0.000 abstract description 11
- 241001506766 Xanthium Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 36
- 230000000052 comparative effect Effects 0.000 description 22
- 206010039083 rhinitis Diseases 0.000 description 21
- 239000000463 material Substances 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 238000005406 washing Methods 0.000 description 9
- 241001251949 Xanthium sibiricum Species 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000002262 irrigation Effects 0.000 description 5
- 238000003973 irrigation Methods 0.000 description 5
- 235000017519 Artemisia princeps Nutrition 0.000 description 4
- 244000065027 Artemisia princeps Species 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 210000002850 nasal mucosa Anatomy 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 208000010753 nasal discharge Diseases 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 206010041232 sneezing Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 235000001405 Artemisia annua Nutrition 0.000 description 1
- 240000000011 Artemisia annua Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010052437 Nasal discomfort Diseases 0.000 description 1
- 206010051181 Nasal odour Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 229960005162 oxymetazoline hydrochloride Drugs 0.000 description 1
- BEEDODBODQVSIM-UHFFFAOYSA-N oxymetazoline hydrochloride Chemical compound Cl.CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 BEEDODBODQVSIM-UHFFFAOYSA-N 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110239600.3A CN112999340A (zh) | 2021-03-04 | 2021-03-04 | 一种鼻腔冲洗液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110239600.3A CN112999340A (zh) | 2021-03-04 | 2021-03-04 | 一种鼻腔冲洗液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112999340A true CN112999340A (zh) | 2021-06-22 |
Family
ID=76405057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110239600.3A Pending CN112999340A (zh) | 2021-03-04 | 2021-03-04 | 一种鼻腔冲洗液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112999340A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101530473A (zh) * | 2009-04-21 | 2009-09-16 | 沈阳双鼎制药有限公司 | 鼻通喷雾剂及其制备方法 |
CN101637546A (zh) * | 2009-08-20 | 2010-02-03 | 曹书光 | 一种治疗急慢性鼻炎、鼻窦炎的药物 |
CN105056060A (zh) * | 2015-07-30 | 2015-11-18 | 吴斌 | 一种用于治疗慢性鼻窦炎的药物 |
CN106619969A (zh) * | 2017-03-14 | 2017-05-10 | 四川香龙丹医药科技有限公司 | 用于治疗鼻炎的鼻腔冲洗液 |
CN106821980A (zh) * | 2017-02-17 | 2017-06-13 | 成都博创必成医药技术有限公司 | 一种鼻腔喷雾剂及其制备方法和生物阻隔膜 |
CN107899006A (zh) * | 2017-11-28 | 2018-04-13 | 四川清舒乐科技有限公司 | 冲洗鼻腔的药物组合物及其制备方法 |
CN108606991A (zh) * | 2016-12-13 | 2018-10-02 | 广州零界医药有限公司 | 一种鼻腔喷雾器冲洗液配方 |
-
2021
- 2021-03-04 CN CN202110239600.3A patent/CN112999340A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101530473A (zh) * | 2009-04-21 | 2009-09-16 | 沈阳双鼎制药有限公司 | 鼻通喷雾剂及其制备方法 |
CN101637546A (zh) * | 2009-08-20 | 2010-02-03 | 曹书光 | 一种治疗急慢性鼻炎、鼻窦炎的药物 |
CN105056060A (zh) * | 2015-07-30 | 2015-11-18 | 吴斌 | 一种用于治疗慢性鼻窦炎的药物 |
CN108606991A (zh) * | 2016-12-13 | 2018-10-02 | 广州零界医药有限公司 | 一种鼻腔喷雾器冲洗液配方 |
CN106821980A (zh) * | 2017-02-17 | 2017-06-13 | 成都博创必成医药技术有限公司 | 一种鼻腔喷雾剂及其制备方法和生物阻隔膜 |
CN106619969A (zh) * | 2017-03-14 | 2017-05-10 | 四川香龙丹医药科技有限公司 | 用于治疗鼻炎的鼻腔冲洗液 |
CN107899006A (zh) * | 2017-11-28 | 2018-04-13 | 四川清舒乐科技有限公司 | 冲洗鼻腔的药物组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109045061B (zh) | 铁皮石斛多糖在制备治疗骨关节炎药物中的应用 | |
CN114652748A (zh) | 一种含有干细胞抑菌因子的医用妇科洗液的制备方法及其应用 | |
CN116492397A (zh) | 一种提高母牛繁育性能的制剂及其制备方法及提高母牛繁育性能的方法 | |
CN105688197A (zh) | 含溶菌酶的治疗脚气药物 | |
CN112999340A (zh) | 一种鼻腔冲洗液及其制备方法 | |
CN103330781A (zh) | 具有抗肿瘤作用的中药组合物及其注射液的制备方法 | |
CN103599437B (zh) | 一种治疗阴道炎的中药药液 | |
CN106880654B (zh) | 竹节参提取物在制备治疗鼻炎药物中的应用及组合物 | |
WO2019127036A1 (zh) | 预防和治疗结石、高血尿酸、痛风症及其并发症的中药组合物、其制备方法及其应用 | |
CN105596480A (zh) | 一种治疗鼻炎的中药组合物及其制备方法和用其制备洗鼻剂的方法 | |
CN103386101A (zh) | 一种治疗非特异性膀胱炎的中药制剂及其制备方法 | |
CN114053333A (zh) | 一种治疗鼻炎的中药组合物及其制备方法、使用方法 | |
CN109966428B (zh) | 一种鼻咽中药冲洗液配方 | |
CN109260297B (zh) | 一种用于治疗痔疮的中药组合物及其制备方法 | |
CN105497459A (zh) | 一种治疗妇女带下病的中药制剂及其制备方法及应用 | |
CN105998542A (zh) | 一种治疗急性咽喉炎的中药喷剂及其制备方法 | |
CN113940916A (zh) | 一种治疗犬病毒性肝炎的板蓝根注射液及其制备方法 | |
CN103721061A (zh) | 一种治疗慢性鼻窦炎的中药外用制剂及其制备方法 | |
CN117797198A (zh) | 一种用于速愈治疗妇科炎症的中药发酵水凝胶 | |
CN117442688A (zh) | 一种降尿酸的药物组合物及其制备方法 | |
CN117752734A (zh) | 一种补益肝肾复方中药在治疗纤维肌痛综合征中的新用途 | |
CN116370524A (zh) | 一种用于前列腺治疗的中药组合物及其制备方法 | |
CN114869978A (zh) | 一种用于治疗妇科炎症的中药组合物及其制备方法 | |
CN113134032A (zh) | 治疗前列腺增生的药物组合物、舒缓型凝胶及其制备方法 | |
CN113663028A (zh) | 一种治疗结核性溃疡的中药凝胶剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210923 Address after: 1 dongjiaomin lane, Dongcheng District, Beijing Applicant after: BEIJING TONGREN HOSPITAL, CAPITAL MEDICAL University Applicant after: Beijing Institute of Otolaryngology (Beijing otolaryngology head and Neck Surgery Research Center) Applicant after: Beijing Huasheng Medical Technology Development Co.,Ltd. Address before: 1 dongjiaomin lane, Dongcheng District, Beijing Applicant before: BEIJING TONGREN HOSPITAL, CAPITAL MEDICAL University Applicant before: Beijing Institute of Otolaryngology (Beijing otolaryngology head and Neck Surgery Research Center) |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210622 |
|
RJ01 | Rejection of invention patent application after publication |